Feinberg School of Medicine

Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Children’s Memorial Joins Brain Tumor Consortium
Uncategorized

Children’s Memorial Joins Brain Tumor Consortium

By

–

Dec 13, 2002

Memorial Joins Brain Tumor Consortium

The Falk Brain Tumor Center of Children’s Memorial Hospital (CMH) is the newest member of the prestigious Pediatric Brain Tumor Consortium. The Falk Center is the only institution to be accepted into the consortium this year. Other member institutions include the Dana Farber Cancer Institute, Duke University, and Children’s National Medical Center.

Chosen for its high patient volume (100 new patients each year) and multidisciplinary clinical expertise, the Falk Center is directed by Northwestern University faculty members Tadanori Tomita, MD, professor of neurological surgery, with neuro-oncologist Stewart Goldman, MD, associate professor of pediatrics, serving as medical director. Benefits to patients include access to free brain tumor medication through consortium-developed clinical research; CMH will receive reimbursements from the National Cancer Institute.

Education

Latest News

  • Targeting Key Proteins in Fight Against ALS 

    Targeting Key Proteins in Fight Against ALS 

    Jan 22, 2026
  • How Inflammation Fuels Blood Cancer Risk  

    How Inflammation Fuels Blood Cancer Risk  

    Jan 21, 2026
  • Investigating Treatments for Peripheral Artery Disease 

    Investigating Treatments for Peripheral Artery Disease 

    Jan 20, 2026
  • Experimental Drug Shows Promise for Rare Genetic Disorder 

    Experimental Drug Shows Promise for Rare Genetic Disorder 

    Jan 16, 2026
  • New Treatment Directions for Rare Brain Disorder

    New Treatment Directions for Rare Brain Disorder

    Jan 15, 2026
  • Novel Mechanism Regulates Essential Enzyme Production in Kidneys 

    Novel Mechanism Regulates Essential Enzyme Production in Kidneys 

    Jan 14, 2026
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
  • Copyright © 2026 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements